Rational drug design involves the development or modification of a drug that is designed to interact with a specific biological molecule, the biotarget, to provide a therapeutic benefit. many of these drugs are designed to activate or inhibit
a) lipids
b) enzymes
c) nerve cells
d) nucleic acids

Imagine a self-reactive t cell that has not undergone clonal deletion in the thymus (that is to say, it has escaped central tolerance). if it encounters self antigen in the absence of an infection or inflammation, what will happen to this self-reactive t cell? (select two answers) (a) the t cell undergoes clonal expansion. (b) the t cell gains effector functions. (c) the t cell undergoes apoptosis. (d) the t cell becomes activated. (e) the t cell becomes anergic.